Cutaneous fungal infections in the United States: Analysis of the national ambulatory medical care survey (NAMCS) and national hospital ambulatory medical care survey (NHAMCS), 1995-2004

International Journal of Dermatology

Volumn 48, Issue 7, 2009, Pages 704-712

  Panackal, Anil A ^a   Halpern, Elkan F ^a   Watson, Alice J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLYLAMINE DERIVATIVE; ANTIFUNGAL AGENT; GRISEOFULVIN; HYDROXYPYRIDONE DERIVATIVE; IMIDAZOLE; NYSTATIN; POLYENE; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CROSS-SECTIONAL STUDY; DERMATOMYCOSIS; DISEASE CLASSIFICATION; DRUG TREATMENT FAILURE; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; ONYCHOMYCOSIS; OUTPATIENT; PREVALENCE; RACE DIFFERENCE; TINEA CAPITIS; TINEA CORPORIS; TINEA CRURIS; TINEA MANUUM; TINEA PEDIS; TREND STUDY; UNITED STATES;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; ANTIFUNGAL AGENTS; DATA COLLECTION; DERMATOMYCOSES; FEMALE; HEALTH CARE COSTS; HEALTH EXPENDITURES; HUMANS; INSURANCE, HEALTH; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; UNITED STATES; YOUNG ADULT;

EID: 67649203089     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2009.04025.x     Document Type: Article

References (31)

1. Borman AM, Campbell CK, Fraser M, et al. Analysis of the dermatophyte species isolated in the British Isles between 1980 and 2005 and review of worldwide dermatophyte trends over the last three decades. Med Mycol 2007; 45: 131-141.
2. Bickers DR, Lim HW, Margolis D, et al. The burden of skin diseases: 2004. A joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. J Am Acad Dermatol 2006; 55: 490-500.
3. Loo DS. Cutaneous fungal infections in the elderly. Dermatol Clin 2004; 22: 33-50.
4. Foster KW, Ghannoum MA, Elewski BE. Epidemiologic surveillance of cutaneous fungal infection in the United States from 1999 to 2002 J Am Acad Dermatol 2004; 50: 748-752.
5. Suh DC, Friedlander SF, Raut M, et al. Tinea capitis in the United States: Diagnosis, treatment, and costs. J Am Acad Dermatol 2006; 55: 1111-1112.
6. Lobato MN, Vugia DJ, Frieden IJ. Tinea capitis in California children: A population-based study of a growing epidemic. Pediatrics 1997; 99: 551-554.
7. Crawford F. Athlete's foot and fungally infected toe nails. Clin Evid 2002; 7: 1458-1466.
8. Rogers D, Kilkenny M, Marks R. The descriptive epidemiology of tinea pedis in the community. Australas J Dermatol 1996; 37: 178-184.
9. Ghannoum MA, Hajjeh RA, Scher R, et al. A large-scale North American study of fungal isolates from nails: The frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. J Am Acad Dermatol 2000; 43: 641-648.
10. Evans EG. Tinea pedis: Clinical experience and efficacy of short treatment. Dermatology 1997; 194 (Suppl. 1): 3-6.
11. Gupta AK, Batra R, Bluhm R, et al. Pityriasis versicolor. Dermatol Clin 2003; 21: 413-429, v-vi.
12. Gupta AK, Nicol K, Johnson A. Pityriasis versicolor: Quality of studies. J Dermatol Treat 2004; 15: 40-45.
13. National Center for Health Statistics (NCHS). National Ambulatory Medical Care Survey (NAMCS); National Hospital Ambulatory Medical Care Survey (NHAMCS). URL http://www.cdc.gov/nchs/about/major/ahcd/ahcd1.htm, Vol. 2008 [accessed 15 January 2008].
14. National Center for Health Statistics (NCHS). International Classification of Diseases, Ninth Revision, Clinical Modification. URL http://www.cdc.gov/nchs/about/otheract/icd9/abticd9.htm, Vol. 2008 [accessed 15 March 2008].
15. Food and Drug Administration (FDA). National Drug Code Directory Class. URL http://www.fda.gov/cder/ndc/. [accessed 1 February 2008].
16. US Department of Commerce. United States Census. URL http://www.census.gov/. [accessed 1 May 2008].
17. Torres-Rodriguez JM, Lopez-Jodra O. Epidemiology of nail infection due to keratinophilic fungi. Rev Iberoam Micol 2000; 17: 122-135.
18. Tack DA, Fleishcer A Jr, McMichael A, et al. The epidemic of tinea capitis disproportionately affects school-aged African Americans. Pediatr Dermatol 1999; 16: 75.
19. Crawford F. Athlete's foot. Clin Evid 2004; 12: 2266-2270.
20. Vargo K, Cohen BA. Prevalence of undetected tinea capitis in household members of children with disease. Pediatrics 1993; 92: 155-157.
21. Centers for Medicare and Medicaid Services UDoHaHS. URL http://www.cms.hhs.gov/. [accessed 15 May 2008].
22. Frieden IJ. Tinea capitis: Asymptomatic carriage of infection. Pediatr Infect Dis J 1999; 18: 186-190.
23. Rich P. Onychomycosis and tinea pedis in patients with diabetes. J Am Acad Dermatol 2000; 43: S130-S134.
24. Cribier BJ, Bakshi R. Terbinafine in the treatment of onychomycosis: A review of its efficacy in high-risk populations and in patients with nondermatophyte infections. Br J Dermatol 2004; 150: 414-420.
25. American Society of Health-System Pharmacists. AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists, 2007.
26. Saiman L, Ludington E, Dawson JD, et al. Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J 2001; 20: 1119-1124.
27. Das S, Goyal R, Bhattacharya SN. Laboratory-based epidemiological study of superficial fungal infections. J Dermatol 2007; 34: 248-253.
28. Sarma S, Capoor MR, Deb M, et al. Epidemiologic and clinicomycologic profile of onychomycosis from north India. Int J Dermatol 2008; 47: 584-587.
29. Gupta AK, Jain HC, Lynde CW, et al. Prevalence and epidemiology of onychomycosis in patients visiting physicians'offices: A multicenter Canadian survey of 15,000 patients. J Am Acad Dermatol 2000; 43: 244-248.
30. Gupta AK, Konnikov N, MacDonald P, et al. Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: A multicentre survey. Br J Dermatol 1998; 139: 665-671.
31. Hernan MA, Robins JM. Instruments for causal inference: An epidemiologist's dream? Epidemiology 2006; 17: 360-372.